By Emilie Ruscoe ( July 29, 2020, 5:27 PM EDT) -- Pharmaceutical company Allergan on Tuesday told a New York federal judge not to certify a proposed class of its investors in a stock drop suit it faces, calling the lead plaintiff a "serial litigant" and contending that the trimmed suit didn't show the company's alleged misstatements moved the needle of the company's stock price....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.